Lulu Zhang1,2; Fang Du1,2; Qiqi Jin3,4,5; Li Sun6; Boqian Wang1,2; Ziyang Tan7; Xinyu Meng2; Baozhen Huang8; Yifan Zhan9; Wenqiong Su2; Rui Song1,10; Chunmei Wu1; Luonan Chen3,5,11; Xiaoxiang Chen1; Xianting Ding1,2

1.Department of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital and School of Biomedical Engineering, Shanghai, 200030, China.;
2.State Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200001, China.;
3.Key Laboratory of Systems Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, 200031, China.;
4.University of Chinese Academy of Sciences, Beijing, 100049, China.;
5.School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.;
6.Department of Rheumatology and Immunology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.;
7.Science for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, Solna, 17121, Sweden.;
8.Department of Chemical Pathology, Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, 999077, China.;
9.Drug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, 200131, China.;
10.Nantong First People's Hospital, Affiliated Hospital 2 of Nantong University, Nantong Hospital of Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine.;
11.Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Hangzhou, 310024, China.